VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 514 filers reported holding VANECK VECTORS ETF TR in Q1 2020. The put-call ratio across all filers is 0.82 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $207,799 | -8.9% | 7,722 | +2.0% | 0.01% | +22.2% |
| Q2 2023 | $227,993 | -46.2% | 7,572 | -39.4% | 0.01% | -57.1% |
| Q2 2021 | $424,000 | +4.4% | 12,490 | 0.0% | 0.02% | -4.5% |
| Q1 2021 | $406,000 | -99.9% | 12,490 | +3.8% | 0.02% | -12.0% |
| Q4 2020 | $433,213,000 | -8.0% | 12,027 | 0.0% | 0.02% | -19.4% |
| Q3 2020 | $470,977,000 | +118833.6% | 12,027 | +11.4% | 0.03% | +520.0% |
| Q2 2020 | $396,000 | -24.6% | 10,800 | -52.6% | 0.01% | -54.5% |
| Q1 2020 | $525,000 | +101.1% | 22,800 | +99.6% | 0.01% | -45.0% |
| Q1 2017 | $261,000 | +2.8% | 11,421 | -6.0% | 0.02% | -9.1% |
| Q4 2016 | $254,000 | -25.9% | 12,148 | -6.3% | 0.02% | -29.0% |
| Q3 2016 | $343,000 | -21.7% | 12,965 | -18.0% | 0.03% | -27.9% |
| Q2 2016 | $438,000 | – | 15,816 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |